Swissmedic Therapeutic Products Safety Communications DHPCs Batch Recalls
Summary
Swissmedic publishes consolidated listings of Direct Healthcare Professional Communications (DHPCs), Health Professional Communications (HPCs), batch recalls, and quality defect notices for human medicinal products, medical devices, and veterinary medicines. The listings include dates, affected product names, and the nature of the safety issue (e.g., potential visible particles after reconstitution, risk of severe hypercalcaemia, non-conforming sterility testing). No specific compliance actions or deadlines are imposed by this aggregation page itself.
About this source
GovPing monitors Swissmedic News for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
Swissmedic maintains an ongoing page aggregating all current Direct Healthcare Professional Communications (DHPCs) and Health Professional Communications (HPCs) for human medicinal products, alongside batch recalls and out-of-stock notifications. Entries include product names (Spevigo, Kyprolis, Crysvita, Aripiprazol-Mepha, Lacrycon, among others), the nature of the safety concern, and the date of publication. Healthcare professionals and distributors should monitor this page for updates to product safety information relevant to their practice or supply chain.
The page also covers medical device Field Safety Corrective Actions (FSCAs), counterfeit alerts (SmartBone, CHONDROGRID), and veterinary medicine batch recalls and HPCs. While this index page does not itself impose obligations, the individual DHPCs and recall notices it links to contain the operative safety instructions and applicable withdrawal levels (retail, patient, or wholesale).
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Current information on therapeutic products safety
Human medicines
New findings for healthcare professionals concerning the safety of medicinal products (DHPC)
15.04.2026
DHPC – Spevigo® (spesolimabum)
Verzögerter Neudruck der zuletzt genehmigten Packungsbeilage aufgrund der Übertragung der Zulassung 14.04.2026
DHPC – Kyprolis® (carfilzomibum)
Potentielle sichtbare Partikel nach Rekonstitution 01.04.2026
DHPC – Crysvita (Burosumab)
Risiko einer schweren Hyperkalzämie 20.03.2026
HPC – Lisdexamfetamindimesylat
Kontraindikation für Patienten mit Phäochromozytom 12.03.2026
DHPC – Citrate d'Yttrium (90Y)-YMM-1 (yttrii(90-Y) citras)
Nicht konforme Sterilitätsprüfung nach Freigabe
General announcements, warnings, quality defects, batch recalls and out-of-stock situations
17.04.2026
Batch recall – Allergovit Parietaria Injektionssuspension
Rückzug der Charge 6G2311031-04 bis auf Stufe Detailhandel 16.04.2026
Batch recall – Aripiprazol-Mepha 5 mg
Rückzug der Charge 173159 bis auf Stufe Detailhandel 16.04.2026
Batch recall – Lacrycon Augengel in Einzeldosen
Rückzug der Chargen 6V55, 7V27, 7V91, 1X27, 9V84 und 2X79 bis auf Stufe Patient 10.04.2026
Out-of-Stock – Physioneal 40 Clear-Flex 2.27% Peritonealdialyselösung
Befristete Bewilligung zum Vertrieb in österreichischer Aufmachung 01.04.2026
Batch recall – Tannosynt flüssig Konzentrat zur Herstellung einer Lösung zur Anwendung auf der Haut
Rückzug der Chargen 331432 und 528831 bis auf Stufe Detailhandel 01.04.2026
Out-of-Stock – Omjjara Filmtabletten
Befristete Bewilligung zum Vertrieb in tschechischer/polnischer/griechischer Aufmachung
Medical devices
List of Field Safety Corrective Actions (FSCA) and recalls
List of FSCAs
Warnings and counterfeits
09.07.2025
Warning concerning Smileie aligners
Swissmedic recommends that Smileie aligners should henceforth no longer be used 29.04.2025
Counterfeit of the medical device SmartBone®, bone substitute, from lndustrie Biomediche lnsubri SA
Safety notice 03.07.2024
Counterfeit medical device CHONDROGRID® - INJECTABLE COLLAGEN HYDROLYSATE - 1 BTL 4MG from Bioteck S.p.A.
Safety notice
Veterinary medicines
Findings concerning product risks of veterinary medicinal products
19.09.2025
HPC – Neptra ad us. vet. (Florfenicol/ Terbinafinhydrochlorid/ Mometasonfuroat)
Neue unerwünschte Wirkung 27.08.2025
HPC – Osurnia ad us. vet. (Terbinafin / Florfenicol / Betamethasonacetat)
Zusätzliche Nebenwirkungen: Überempfindlichkeit und Nebenwirkungen am Auge 12.06.2025
HPC – Injektionslösungen mit dem Wirkstoff Ketoprofen für Tiere
Sehr seltene Fälle von Überempfindlichkeitsreaktionen
Quality defects, batch recalls and out-of-Stock
15.10.2025
Batch recall – Nobivac DHPPi ad us. vet. Lyophilisat zur Herstellung einer Injektionssuspension für Hunde
Rückruf der Charge A777B01 bis auf Stufe Detailhandel 07.10.2025
Batch recall – Gonavet Veyx ad us. vet. 10 ml / 50ml Injektionslösung für Rinder, Schweine und Pferde
Rückruf der Chargen 24G253, 24B072, 24L029 und 23K022 bis auf Stufe Detailhandel 07.10.2025
Batch recall – Maprelin ad us. vet. 10 ml Injektionslösung für Schweine
Rückruf der Chargen 25A061, 24E075, 24C291 und 23J034 bis auf Stufe Detailhandel Last modification 11.02.2022
Related changes
Get daily alerts for Swissmedic News
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Swissmedic.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Swissmedic News publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.